FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine, in particular, to medication, representing deanol aceglumate and possessing antiulcerogenic, gastro- and enteroprotective activity, and its combinations with anti-inflammatory, or anti-ulcer medications, or with anti-inflammatory and anti-ulcer medications.
EFFECT: medication possesses high antiulcerogenic, gastro- and enteroprotective activity, reduces side NSAID-induced ulcerative lesions of stomach and intestine.
6 cl, 2 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS WITH GASTROPROTECTIVE ACTIVITY | 2016 |
|
RU2629090C1 |
3-[3-(MORPHOLINE-4-YL)PROPYL]-2-[(2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-YL)METHYL-1,3-THIAZOLIDINE-4-ONE WITH ANTI-ULCER AND ANTI-INFLAMMATORY ACTIVITY | 2017 |
|
RU2643669C1 |
BIOLOGICALLY ACTIVE FOOD SUPPLEMENT "BIOSINOL", WHICH POSSESSES GASTROPROTECTIVE ACTIVITY | 2009 |
|
RU2397775C1 |
PHARMACEUTICAL, POSSESSING A GASTROPROTECTIVE (ANTIULCER) ACTIVITY | 2016 |
|
RU2637644C1 |
METHOD FOR PREVENTION OF ULCERATION OF GASTRIC MUCOSA | 2020 |
|
RU2744455C1 |
PREPARATION, POSSESSING GASTROPROTECTIVE ACTIVITY | 2014 |
|
RU2536225C1 |
DRUGS FOR TREATMENT OF PATIENTS WITH INFLAMMATORY STATES OR FOR ANALGESIA | 1992 |
|
RU2134579C1 |
METHOD OF GASTER ULCER TREATMENT IN EXPERIMENT | 1992 |
|
RU2057530C1 |
AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 |
|
RU2814495C1 |
METHOD OF PREVENTION OF STOMACH ULCER LESION CAUSED BY NONSTEROID ANTIINFLAMMATORY AGENTS | 2007 |
|
RU2330671C1 |
Authors
Dates
2011-12-10—Published
2010-02-03—Filed